hcp-engagement
(11)
The Deck That Went Nowhere
A year of careful medical-communications work once died unused in the field. Kinetix Health Group is betting that pharma does not need another deck - it needs a system that keeps evidence moving.
The Medical Meeting That Refuses to End
Impact Communication Partners has spent more than four decades translating complicated science for healthcare professionals. Its sharpest idea is also its simplest: the best answer may arrive after the meeting is over.
The Agency Behind the Medicine Behind the Message
HCG built a business around an awkward truth: a medicine can work perfectly in a trial and still fail in the world if nobody understands it. Its answer was to put scientists, storytellers, designers, and regulatory specialists at the same table.
The Medical Meeting That Wouldn’t Stay Small
One advisory board, a folding table and 3,000 envelopes became a 25-year medical communications company. JB Ashtin’s real product is the thing agencies rarely put on an invoice: trust under pressure.
The Medical Meeting Is Only the Visible Part of Insyght’s Work
For three decades, the Santa Monica firm has worked behind the scenes where science, logistics and pharmaceutical compliance collide. Its real product is not the meeting, the slide deck or the app - it is making all three agree.
Healthcasts Spent 25 Years Turning the Doctors’ Hallway Conversation Into a Search Engine
The company started by streaming medical seminars at a fraction of the cost. Now it is betting that the most useful answer in medicine is often the one a verified peer has already learned the hard way.
Aktana
Aktana spent years turning pharma’s scattered customer data into a daily recommendation engine. Now, under PharmaForceIQ, its field intelligence is being stitched to digital orchestration in a bid to close one of life sciences’ most expensive gaps.
G LNK
G LNK is a New York-based healthcare commercial intelligence platform (Y Combinator W25) that helps pharma, biotech, and medtech teams find the right medical experts, benchmark fair-market compensation, and stay compliant. Its AI search sits on a searchable clinician database - 9.2M+ HCP profiles at last count - and automates the full lifecycle of engaging healthcare professionals, from identification and tiering to compliant payment and regulatory oversight across 150+ countries.
Evermed
Evermed is a New York-based health-tech company that helps medical associations and societies turn conference recordings and educational archives into Netflix-style, AI-personalized content libraries. Its software-plus-services model lets organizations launch and operate a branded on-demand education hub in roughly 90 days without expanding staff or wrestling with technology, while unlocking new revenue through subscriptions and industry sponsorships. Founded around 2018-2019 by Bozidar Jovicevic, MD, MBA and co-founder Elia Fedorovski, Evermed powers education libraries used by clinicians in more than 120 countries and partners with major U.S. medical associations including the American College of Cardiology, ACEP, CHEST, CAP and ASA.
Synthio Labs
Synthio Labs builds clinical-grade voice and agentic AI for life sciences customer engagement. Its platform helps pharma field teams, medical affairs, and patient-support orgs run compliant, continuous conversations across HCPs and patients, powered by a clinical reasoning engine that ingests FDA labels and real-world evidence.
Cutting Edge Information
Cutting Edge Information (CEI) is a Research Triangle Park-based market research and data analytics firm that builds the world's largest specialty-specific database of Fair Market Value (FMV) rates for engaging healthcare professionals. Pharmaceutical, biotech, and medical device companies use CEI's FMV data, HCP Fee Calculator, and Compliance Insights to set rates that are both competitive enough to attract top clinical talent and defensible enough to satisfy regulators. With 230,000+ rate observations across 126 countries and 280+ specialties, CEI serves more than 300 clients, including over 70% of the top 25 pharmaceutical companies and 8 of the top 10.